Abstract
Currently, there are no reliable RBC invasion assays to guide the discovery of vaccines against Plasmodium vivax, the most prevalent malaria parasite in Asia and South America. Here we describe a protocol for an ex vivo P vivax invasion assay that can be easily deployed in laboratories located in endemic countries. The assay is based on mixing enriched cord blood reticulocytes with matured, trypsin-treated P vivax schizonts concentrated from clinical isolates. The reliability of this assay was demonstrated using a large panel of P vivax isolates freshly collected from patients in Thailand.
Original language | English |
---|---|
Pages (from-to) | e74-81 |
Journal | Blood |
Volume | 118 |
Issue number | 13 |
DOIs | |
Publication status | Published - 29 Sept 2011 |
Keywords
- Cells, Cultured
- Hematologic Tests
- High-Throughput Screening Assays
- Host-Pathogen Interactions
- Humans
- Malaria, Vivax
- Plasmodium vivax
- Reproducibility of Results
- Reticulocytes
- Evaluation Studies
- Journal Article
- Research Support, Non-U.S. Gov't
- Validation Studies